APO Research
Talk to an analyst

APO RESEARCH · REPORT

Eucommia Ulmoides Granules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Eucommia Ulmoides Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025194 pages

Choose your research edition.

Industry ResearchEucommia Ulmoides Granules Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Eucommia Ulmoides Granules Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Eucommia Ulmoides Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Eucommia Ulmoides Granules Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Eucommia Ulmoides Granules Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Eucommia Ulmoides Granules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Eucommia Ulmoides Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Eucommia Ulmoides Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Eucommia Ulmoides Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Eucommia Ulmoides Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Eucommia Ulmoides Granules include Guizhou Runsheng Pharmaceutical Co., Ltd., Guizhou Shenqi Pharmaceutical Co., Ltd., Guizhou Shengjitang Pharmaceutical Co., Ltd., Huangshan Tianmu Pharmaceutical Co., Ltd., Huiyinbi Group Anhui Pharmaceutical Co., Ltd., Jilin Zixin Pharmaceutical Co., Ltd., Nanjing Tongrentang Pharmaceutical Co., Ltd., Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. and Shandong Buchang Shenzhou Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Eucommia Ulmoides Granules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Eucommia Ulmoides Granules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Eucommia Ulmoides Granules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Eucommia Ulmoides Granules market size, projected growth trends, production technologies, key applications, and end-use industries.

Eucommia Ulmoides Granules Segment by Company

Guizhou Runsheng Pharmaceutical Co., Ltd.

Guizhou Shenqi Pharmaceutical Co., Ltd.

Guizhou Shengjitang Pharmaceutical Co., Ltd.

Huangshan Tianmu Pharmaceutical Co., Ltd.

Huiyinbi Group Anhui Pharmaceutical Co., Ltd.

Jilin Zixin Pharmaceutical Co., Ltd.

Nanjing Tongrentang Pharmaceutical Co., Ltd.

Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd.

Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.

Sichuan Shenghe Pharmaceutical Co., Ltd.

Wuhu Luye Pharmaceutical Co., Ltd.

Xi'an Zhengda Pharmaceutical Co., Ltd.

Eucommia Ulmoides Granules Segment by Type

5g Per Bag

10g Per Bag

Eucommia Ulmoides Granules Segment by Application

Hospital

Clinic

Other

Eucommia Ulmoides Granules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eucommia Ulmoides Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Eucommia Ulmoides Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eucommia Ulmoides Granules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Eucommia Ulmoides Granules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Eucommia Ulmoides Granules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Eucommia Ulmoides Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Eucommia Ulmoides Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Eucommia Ulmoides Granules Industry Trends Table 2. Eucommia Ulmoides Granules Industry Drivers Table 3. Eucommia Ulmoides Granules Industry Opportunities and Challenges Table 4. Eucommia Ulmoides Granules Industry Restraints Table 5. Global Eucommia Ulmoides Granules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Eucommia Ulmoides Granules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Eucommia Ulmoides Granules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Eucommia Ulmoides Granules Sales Market Share by Manufacturers Table 9. Global Eucommia Ulmoides Granules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Eucommia Ulmoides Granules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Eucommia Ulmoides Granules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Eucommia Ulmoides Granules Manufacturers, Product Type & Application Table 13. Global Eucommia Ulmoides Granules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Eucommia Ulmoides Granules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5g Per Bag Table 17. Major Manufacturers of 10g Per Bag Table 18. Global Eucommia Ulmoides Granules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Eucommia Ulmoides Granules Sales by Type (2021-2026) & (K Units) Table 20. Global Eucommia Ulmoides Granules Sales by Type (2027-2032) & (K Units) Table 21. Global Eucommia Ulmoides Granules Sales Market Share by Type (2021-2026) Table 22. Global Eucommia Ulmoides Granules Sales Market Share by Type (2027-2032) Table 23. Global Eucommia Ulmoides Granules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Eucommia Ulmoides Granules Revenue by Type (2021-2026) & (K Units) Table 25. Global Eucommia Ulmoides Granules Revenue by Type (2027-2032) & (K Units) Table 26. Global Eucommia Ulmoides Granules Revenue Market Share by Type (2021-2026) Table 27. Global Eucommia Ulmoides Granules Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Eucommia Ulmoides Granules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Eucommia Ulmoides Granules Sales by Application (2021-2026) & (K Units) Table 33. Global Eucommia Ulmoides Granules Sales by Application (2027-2032) & (K Units) Table 34. Global Eucommia Ulmoides Granules Sales Market Share by Application (2021-2026) Table 35. Global Eucommia Ulmoides Granules Sales Market Share by Application (2027-2032) Table 36. Global Eucommia Ulmoides Granules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Eucommia Ulmoides Granules Revenue by Application (2021-2026) & (K Units) Table 38. Global Eucommia Ulmoides Granules Revenue by Application (2027-2032) & (K Units) Table 39. Global Eucommia Ulmoides Granules Revenue Market Share by Application (2021-2026) Table 40. Global Eucommia Ulmoides Granules Revenue Market Share by Application (2027-2032) Table 41. Global Eucommia Ulmoides Granules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Eucommia Ulmoides Granules Sales by Region (2021-2026) & (K Units) Table 43. Global Eucommia Ulmoides Granules Sales Market Share by Region (2021-2026) Table 44. Global Eucommia Ulmoides Granules Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Eucommia Ulmoides Granules Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Eucommia Ulmoides Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Eucommia Ulmoides Granules Sales by Country (2021-2026) & (K Units) Table 48. North America Eucommia Ulmoides Granules Sales by Country (2027-2032) & (K Units) Table 49. Europe Eucommia Ulmoides Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Eucommia Ulmoides Granules Sales by Country (2021-2026) & (K Units) Table 51. Europe Eucommia Ulmoides Granules Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Eucommia Ulmoides Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Eucommia Ulmoides Granules Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Eucommia Ulmoides Granules Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Eucommia Ulmoides Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Eucommia Ulmoides Granules Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Eucommia Ulmoides Granules Sales by Country (2027-2032) & (K Units) Table 58. Global Eucommia Ulmoides Granules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Eucommia Ulmoides Granules Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Eucommia Ulmoides Granules Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Eucommia Ulmoides Granules Revenue Market Share by Region (2021-2026) Table 62. Global Eucommia Ulmoides Granules Revenue Market Share by Region (2027-2032) Table 63. Guizhou Runsheng Pharmaceutical Co., Ltd. Company Information Table 64. Guizhou Runsheng Pharmaceutical Co., Ltd. Business Overview Table 65. Guizhou Runsheng Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Guizhou Runsheng Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 67. Guizhou Runsheng Pharmaceutical Co., Ltd. Recent Development Table 68. Guizhou Shenqi Pharmaceutical Co., Ltd. Company Information Table 69. Guizhou Shenqi Pharmaceutical Co., Ltd. Business Overview Table 70. Guizhou Shenqi Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Guizhou Shenqi Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 72. Guizhou Shenqi Pharmaceutical Co., Ltd. Recent Development Table 73. Guizhou Shengjitang Pharmaceutical Co., Ltd. Company Information Table 74. Guizhou Shengjitang Pharmaceutical Co., Ltd. Business Overview Table 75. Guizhou Shengjitang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Guizhou Shengjitang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 77. Guizhou Shengjitang Pharmaceutical Co., Ltd. Recent Development Table 78. Huangshan Tianmu Pharmaceutical Co., Ltd. Company Information Table 79. Huangshan Tianmu Pharmaceutical Co., Ltd. Business Overview Table 80. Huangshan Tianmu Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Huangshan Tianmu Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 82. Huangshan Tianmu Pharmaceutical Co., Ltd. Recent Development Table 83. Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Company Information Table 84. Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Business Overview Table 85. Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 87. Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Recent Development Table 88. Jilin Zixin Pharmaceutical Co., Ltd. Company Information Table 89. Jilin Zixin Pharmaceutical Co., Ltd. Business Overview Table 90. Jilin Zixin Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Jilin Zixin Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 92. Jilin Zixin Pharmaceutical Co., Ltd. Recent Development Table 93. Nanjing Tongrentang Pharmaceutical Co., Ltd. Company Information Table 94. Nanjing Tongrentang Pharmaceutical Co., Ltd. Business Overview Table 95. Nanjing Tongrentang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Nanjing Tongrentang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 97. Nanjing Tongrentang Pharmaceutical Co., Ltd. Recent Development Table 98. Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Company Information Table 99. Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Business Overview Table 100. Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 102. Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Recent Development Table 103. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Company Information Table 104. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Business Overview Table 105. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 107. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Recent Development Table 108. Sichuan Shenghe Pharmaceutical Co., Ltd. Company Information Table 109. Sichuan Shenghe Pharmaceutical Co., Ltd. Business Overview Table 110. Sichuan Shenghe Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sichuan Shenghe Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 112. Sichuan Shenghe Pharmaceutical Co., Ltd. Recent Development Table 113. Wuhu Luye Pharmaceutical Co., Ltd. Company Information Table 114. Wuhu Luye Pharmaceutical Co., Ltd. Business Overview Table 115. Wuhu Luye Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Wuhu Luye Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 117. Wuhu Luye Pharmaceutical Co., Ltd. Recent Development Table 118. Xi'an Zhengda Pharmaceutical Co., Ltd. Company Information Table 119. Xi'an Zhengda Pharmaceutical Co., Ltd. Business Overview Table 120. Xi'an Zhengda Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Xi'an Zhengda Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 122. Xi'an Zhengda Pharmaceutical Co., Ltd. Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Eucommia Ulmoides Granules Distributors List Table 126. Eucommia Ulmoides Granules Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Eucommia Ulmoides Granules Product Image Figure 2. Global Eucommia Ulmoides Granules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Eucommia Ulmoides Granules Market Size (2021-2032) & (US$ Million) Figure 4. Global Eucommia Ulmoides Granules Sales (2021-2032) & (K Units) Figure 5. Global Eucommia Ulmoides Granules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Eucommia Ulmoides Granules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5g Per Bag Image Figure 9. 10g Per Bag Image Figure 10. Global Eucommia Ulmoides Granules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Eucommia Ulmoides Granules Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Eucommia Ulmoides Granules Sales Market Share by Type (2021-2032) Figure 13. Global Eucommia Ulmoides Granules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Eucommia Ulmoides Granules Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Eucommia Ulmoides Granules Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Eucommia Ulmoides Granules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Eucommia Ulmoides Granules Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Eucommia Ulmoides Granules Sales Market Share by Application (2021-2032) Figure 22. Global Eucommia Ulmoides Granules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Eucommia Ulmoides Granules Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Eucommia Ulmoides Granules Revenue Market Share by Application (2021-2032) Figure 25. North America Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Eucommia Ulmoides Granules Sales Market Share by Country (2021-2032) Figure 27. U.S. Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Eucommia Ulmoides Granules Sales Market Share by Country (2021-2032) Figure 32. Germany Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Eucommia Ulmoides Granules Sales Market Share by Country (2021-2032) Figure 39. China Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Eucommia Ulmoides Granules Sales Market Share by Country (2021-2032) Figure 47. Brazil Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Eucommia Ulmoides Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Eucommia Ulmoides Granules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Eucommia Ulmoides Granules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Eucommia Ulmoides Granules Revenue (2021-2032) & (US$ Million) Figure 58. North America Eucommia Ulmoides Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Eucommia Ulmoides Granules Revenue (2021-2032) & (US$ Million) Figure 60. Europe Eucommia Ulmoides Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Eucommia Ulmoides Granules Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Eucommia Ulmoides Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Eucommia Ulmoides Granules Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Eucommia Ulmoides Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Eucommia Ulmoides Granules Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Eucommia Ulmoides Granules Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 5g Per Bag
  • 10g Per Bag
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Guizhou Runsheng Pharmaceutical Co., Ltd.
  • Guizhou Shenqi Pharmaceutical Co., Ltd.
  • Guizhou Shengjitang Pharmaceutical Co., Ltd.
  • Huangshan Tianmu Pharmaceutical Co., Ltd.
  • Huiyinbi Group Anhui Pharmaceutical Co., Ltd.
  • Jilin Zixin Pharmaceutical Co., Ltd.
  • Nanjing Tongrentang Pharmaceutical Co., Ltd.
  • Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd.
  • Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.
  • Sichuan Shenghe Pharmaceutical Co., Ltd.
  • Wuhu Luye Pharmaceutical Co., Ltd.
  • Xi'an Zhengda Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Eucommia Ulmoides Granules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Eucommia Ulmoides Granules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Eucommia Ulmoides Granules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Eucommia Ulmoides Granules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Eucommia Ulmoides Granules Market Dynamics
  1. 2.1 Eucommia Ulmoides Granules Industry Trends
  2. 2.2 Eucommia Ulmoides Granules Industry Drivers
  3. 2.3 Eucommia Ulmoides Granules Industry Opportunities and Challenges
  4. 2.4 Eucommia Ulmoides Granules Industry Restraints
3 Eucommia Ulmoides Granules Market by Manufacturers
  1. 3.1 Global Eucommia Ulmoides Granules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Eucommia Ulmoides Granules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Eucommia Ulmoides Granules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Eucommia Ulmoides Granules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Eucommia Ulmoides Granules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Eucommia Ulmoides Granules Manufacturers, Product Type & Application
  7. 3.7 Global Eucommia Ulmoides Granules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Eucommia Ulmoides Granules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Eucommia Ulmoides Granules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Eucommia Ulmoides Granules Tier 1, Tier 2, and Tier 3
4 Eucommia Ulmoides Granules Market by Type
  1. 4.1 Eucommia Ulmoides Granules Type Introduction
  2. 4.1.1 5g Per Bag
  3. 4.1.2 10g Per Bag
  4. 4.2 Global Eucommia Ulmoides Granules Sales by Type
  5. 4.2.1 Global Eucommia Ulmoides Granules Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Eucommia Ulmoides Granules Sales by Type (2021-2032)
  7. 4.2.3 Global Eucommia Ulmoides Granules Sales Market Share by Type (2021-2032)
  8. 4.3 Global Eucommia Ulmoides Granules Revenue by Type
  9. 4.3.1 Global Eucommia Ulmoides Granules Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Eucommia Ulmoides Granules Revenue by Type (2021-2032)
  11. 4.3.3 Global Eucommia Ulmoides Granules Revenue Market Share by Type (2021-2032)
5 Eucommia Ulmoides Granules Market by Application
  1. 5.1 Eucommia Ulmoides Granules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Eucommia Ulmoides Granules Sales by Application
  6. 5.2.1 Global Eucommia Ulmoides Granules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Eucommia Ulmoides Granules Sales by Application (2021-2032)
  8. 5.2.3 Global Eucommia Ulmoides Granules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Eucommia Ulmoides Granules Revenue by Application
  10. 5.3.1 Global Eucommia Ulmoides Granules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Eucommia Ulmoides Granules Revenue by Application (2021-2032)
  12. 5.3.3 Global Eucommia Ulmoides Granules Revenue Market Share by Application (2021-2032)
6 Global Eucommia Ulmoides Granules Sales by Region
  1. 6.1 Global Eucommia Ulmoides Granules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Eucommia Ulmoides Granules Sales by Region (2021-2032)
  3. 6.2.1 Global Eucommia Ulmoides Granules Sales by Region (2021-2026)
  4. 6.2.2 Global Eucommia Ulmoides Granules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Eucommia Ulmoides Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Eucommia Ulmoides Granules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Eucommia Ulmoides Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Eucommia Ulmoides Granules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Eucommia Ulmoides Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Eucommia Ulmoides Granules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Eucommia Ulmoides Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Eucommia Ulmoides Granules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Eucommia Ulmoides Granules Revenue by Region
  1. 7.1 Global Eucommia Ulmoides Granules Revenue by Region
  2. 7.1.1 Global Eucommia Ulmoides Granules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Eucommia Ulmoides Granules Revenue by Region (2021-2026)
  4. 7.1.3 Global Eucommia Ulmoides Granules Revenue by Region (2027-2032)
  5. 7.1.4 Global Eucommia Ulmoides Granules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Eucommia Ulmoides Granules Revenue (2021-2032)
  8. 7.2.2 North America Eucommia Ulmoides Granules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Eucommia Ulmoides Granules Revenue (2021-2032)
  11. 7.3.2 Europe Eucommia Ulmoides Granules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Eucommia Ulmoides Granules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Eucommia Ulmoides Granules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Eucommia Ulmoides Granules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Eucommia Ulmoides Granules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Guizhou Runsheng Pharmaceutical Co., Ltd.
  2. 8.1.1 Guizhou Runsheng Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Guizhou Runsheng Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Guizhou Runsheng Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Guizhou Runsheng Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  6. 8.1.5 Guizhou Runsheng Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Guizhou Shenqi Pharmaceutical Co., Ltd.
  8. 8.2.1 Guizhou Shenqi Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Guizhou Shenqi Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Guizhou Shenqi Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Guizhou Shenqi Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  12. 8.2.5 Guizhou Shenqi Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Guizhou Shengjitang Pharmaceutical Co., Ltd.
  14. 8.3.1 Guizhou Shengjitang Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Guizhou Shengjitang Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Guizhou Shengjitang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Guizhou Shengjitang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  18. 8.3.5 Guizhou Shengjitang Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Huangshan Tianmu Pharmaceutical Co., Ltd.
  20. 8.4.1 Huangshan Tianmu Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Huangshan Tianmu Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Huangshan Tianmu Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Huangshan Tianmu Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  24. 8.4.5 Huangshan Tianmu Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Huiyinbi Group Anhui Pharmaceutical Co., Ltd.
  26. 8.5.1 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  30. 8.5.5 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Jilin Zixin Pharmaceutical Co., Ltd.
  32. 8.6.1 Jilin Zixin Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Jilin Zixin Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Jilin Zixin Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jilin Zixin Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  36. 8.6.5 Jilin Zixin Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Nanjing Tongrentang Pharmaceutical Co., Ltd.
  38. 8.7.1 Nanjing Tongrentang Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Nanjing Tongrentang Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Nanjing Tongrentang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nanjing Tongrentang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  42. 8.7.5 Nanjing Tongrentang Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd.
  44. 8.8.1 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  48. 8.8.5 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.
  50. 8.9.1 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  54. 8.9.5 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Sichuan Shenghe Pharmaceutical Co., Ltd.
  56. 8.10.1 Sichuan Shenghe Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Sichuan Shenghe Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Sichuan Shenghe Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sichuan Shenghe Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  60. 8.10.5 Sichuan Shenghe Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Wuhu Luye Pharmaceutical Co., Ltd.
  62. 8.11.1 Wuhu Luye Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Wuhu Luye Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Wuhu Luye Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Wuhu Luye Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  66. 8.11.5 Wuhu Luye Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Xi'an Zhengda Pharmaceutical Co., Ltd.
  68. 8.12.1 Xi'an Zhengda Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Xi'an Zhengda Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Xi'an Zhengda Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Xi'an Zhengda Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  72. 8.12.5 Xi'an Zhengda Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Eucommia Ulmoides Granules Value Chain Analysis
  2. 9.1.1 Eucommia Ulmoides Granules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Eucommia Ulmoides Granules Production Mode & Process
  6. 9.2 Eucommia Ulmoides Granules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Eucommia Ulmoides Granules Distributors
  9. 9.2.3 Eucommia Ulmoides Granules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst